Cargando…
Uridine prevents tamoxifen-induced liver lipid droplet accumulation
BACKGROUND: Tamoxifen, an agonist of estrogen receptor, is widely prescribed for the prevention and long-term treatment of breast cancer. A side effect of tamoxifen is fatty liver, which increases the risk for non-alcoholic fatty liver disease. Prevention of tamoxifen-induced fatty liver has the pot...
Autores principales: | Le, Thuc T, Urasaki, Yasuyo, Pizzorno, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064512/ https://www.ncbi.nlm.nih.gov/pubmed/24887406 http://dx.doi.org/10.1186/2050-6511-15-27 |
Ejemplares similares
-
Uridine Prevents Fenofibrate-Induced Fatty Liver
por: Le, Thuc T., et al.
Publicado: (2014) -
Chronic Uridine Administration Induces Fatty Liver and Pre-Diabetic Conditions in Mice
por: Urasaki, Yasuyo, et al.
Publicado: (2016) -
Uridine Affects Liver Protein Glycosylation, Insulin Signaling, and Heme Biosynthesis
por: Urasaki, Yasuyo, et al.
Publicado: (2014) -
Label-free Evaluation of Hepatic Microvesicular Steatosis with Multimodal Coherent Anti-Stokes Raman Scattering Microscopy
por: Le, Thuc T., et al.
Publicado: (2012) -
Functional Complementation of Anti-Adipogenic Phytonutrients for Obesity Prevention and Management
por: Urasaki, Yasuyo, et al.
Publicado: (2022)